Stockholders' Equity

6 Months Ended

Dec. 31, 2019

Stockholders' Equity Note [Abstract]

STOCKHOLDERS' EQUITY

NOTE 5:- STOCKHOLDERS' EQUITY

a. Pursuant to a shelf registration on Form S-3 declared effective by the Securities and Exchange Commission on June 23, 2017 (the "Form S-3"), in July 2017 the Company entered into an At Market Issuance Sales Agreement ("ATM Agreement") with FBR Capital Markets & Co., MLV & Co. LLC and Oppenheimer & Co. Inc. (collectively, the "Agents"), which provides that, upon the terms and subject to the conditions and limitations in the ATM Agreement, the Company may elect, from time to time, to offer and sell shares of common stock having an aggregate offering price of up to $80,000 through the Agents acting as sales agent. During the six month period ended December 31, 2018, the Company sold 170,600 shares of common stock under the ATM Agreement at an average price of $12.30 per share for aggregate net proceeds of approximately $1,952, net of issuance expenses of $148. On February 4, 2019, the Company notified the Agents of the termination of the ATM Agreement.

b. Pursuant to the Form S-3, on February 6, 2019 the Company entered into the Sales Agreement with Jefferies which provides that, upon the terms and subject to the conditions and limitations in the Sales Agreement, the Company may elect, from time to time, to offer and sell shares of common stock having an aggregate offering price of up to $50,000 through Jefferies acting as sales agent. During the six month period ended December 31, 2019, the Company sold 1,644,118 shares of common stock under the Sales Agreement at an average price of $4.12 per share for aggregate net proceeds of approximately $5,967, net of issuance expenses of $812.

c. Options to non-employees:

A summary of the options to non-employee consultants under its 2005 and 2016 incentive option plans is as follows:

	Six months ended December 31, 2019 (Unaudited)
	Number			Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options outstanding at beginning of period		89,580		$	-		-		-
Options granted		-			-		-		-
Options exercised		(5,000	)		-		-		-
Options forfeited		(4,125	)		-		-		-
Options outstanding at end of the period		80,455		$	-		7.57	$	317
Options exercisable at the end of the period		53,118		$	-		8.15	$	209
Options vested and expected to vest		80,455		$	-		7.57	$	317

Compensation expenses related to options granted to consultants were recorded as follows:

	Six months ended December 31,				Three months ended December 31,
	2019		2018		2019		2018
	(Unaudited)				(Unaudited)
Research and development expenses	$	33	$	97	$	15	$	13
General and administrative expenses	$	53	$	27	$	24	$	21
	$	86	$	124	$	39	$	34

d. Restricted stock ("RS") and restricted stock units ("RSUs") to employees, directors and consultants:

1. RS and RSUs to employees and directors:

The following table summarizes the activity related to unvested RS and RSUs granted to employees and directors under the Company's 2005 and 2016 incentive option plans for the six month period ended December 31, 2019 (Unaudited):

	Number
Unvested at the beginning of period		795,633
Granted		18,000
Forfeited		(56,045	)
Vested		(154,208	)
Unvested at the end of the period		603,380
Expected to vest after December 31, 2019		583,360

Compensation expenses related to RS and RSUs granted to employees and directors were recorded as follows:

	Six months ended December 31,				Three months ended December 31,
	2019		2018		2019		2018
	(Unaudited)				(Unaudited)
Research and development expenses	$	414	$	440	$	192	$	121
General and administrative expenses		1,049		1,354		476		623
	$	1,463	$	1,794	$	668	$	744

Unamortized compensation expenses related to RSUs granted to employees and directors to be recognized over an average time of approximately 3.25 years are approximately $2,425.

2. RS and RSUs to consultants:

The following table summarizes the activity related to unvested RS and RSUs granted to consultants under the Company's 2005 and 2016 incentive option plans for the six month period ended December 31, 2019 (Unaudited):

	Number
Unvested at the beginning of period		30,107
Granted		33,000
Vested		(46,947	)
Unvested at the end of the period		16,160

Compensation expenses related to RS and RSUs granted to consultants were recorded as follows:

	Six months ended December 31,				Three months ended December 31,
	2019		2018		2019		2018
	(Unaudited)				(Unaudited)
Research and development expenses	$	23	$	18	$	11	$	(8	)
General and administrative expenses		59		260		49		98
	$	82	$	278	$	60	$	90